Table 3.
Events (n) | Hazard ratio (95% CI) |
p* | ||
---|---|---|---|---|
Placebo | Clodronate | |||
Disease-free survival | 312 | 286 | 0.91 (0.78 – 1.07) | 0.27 |
Overall survival | 167 | 140 | 0.84 (0.67 – 1.05) | 0.13 |
Recurrence-free interval | 177 | 148 | 0.83 (0.67 – 1.04) | 0.10 |
Bone metastasis-free interval |
80 | 61 | 0.77 (0.55 – 1.07) | 0.12 |
Non-bone metastasis-free survival |
105 | 78 | 0.74 (0.55 – 1.00) | 0.047 |
By log-rank test